Alerts will be sent to your verified email
Verify Email
CAPLIPOINT
Insufficient data
Positive for this company
Neutral for this company
Negative for this company
Insufficient data to analyse
Established in 1990, Caplin Point Laboratories is a mid-sized company in India manufacturing APIs, finished formulations, and engaging in research & development, clinical research, and global marketing.
Caplin Point Lab major competitors are Gufic Biosciences, Gland Pharma, Jubilant Pharmova, Natco Pharma, Alembic Pharma, Sanofi India, Astrazeneca Pharma I.
Market Cap of Caplin Point Lab is ₹16,028 Crs.
While the median market cap of its peers are ₹16,557 Crs.
Caplin Point Lab seems to be financially stable compared to its competitors.
The probability of it going bankrupt or facing a financial crunch seem to be lower than its immediate competitors.
| 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | 2010 | |||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Annual Report | FY25 | FY24 | FY23 | FY22 | FY21 | FY20 | FY19 | FY18 | FY17 | FY16 | FY15 | FY14 | FY13 | FY12 | FY11 | FY10 | ||
| Earnings Release | May Aug | Mar Jun Sep Dec | Mar Jun Dec | Mar Jun Sep Dec | Mar Jun Sep Dec | Jun Sep Dec | Mar Sep Dec | Dec | ||||||||||
| Investor Presentation | May Aug | Mar Jun Sep Dec | Mar Jun Sep Dec | Mar Jun Sep Dec | Mar Jun Sep Dec | Mar Jun Sep Dec | Dec | Dec | ||||||||||
| Conference Call | Mar Jun | Mar Jun Sep Dec | Mar Jun Sep Dec | Mar Jun Sep | Mar Jun | Mar Jun Sep Dec | Sep | Dec | ||||||||||
|
Conference Call SummaryCon Call Summary
Powered by Gemini
|
